Home » Authors » James Etheridge

Articles by James Etheridge

NicOx Grants AstraZeneca Exclusive License For Japan

Oct. 1, 2002

By James Etheridge

Neuro3d Raises EUR20M Privately To Fund Work In CNS Disorders

Sep. 25, 2002

By James Etheridge

Genset Shareholders Accept Bid From Serono; Integration Begins

Sep. 25, 2002

By James Etheridge

Genset Shareholders Accept Bid From Serono; Integration Begins

Sep. 25, 2002

By James Etheridge

Neuro3d Raises EUR20M Privately To Fund Work In CNS Disorders

Sep. 25, 2002

By James Etheridge

Euroscreen Granted U.S. Patent Covering Human CCR5 Receptor

Sep. 18, 2002

By James Etheridge

French Researchers Discover Genetic Origin For Colon Cancer

Sep. 18, 2002

By James Etheridge

French Researchers Discover Genetic Origin For Colon Cancer

Sep. 18, 2002

By James Etheridge

Euroscreen Granted U.S. Patent Covering Human CCR5 Receptor

Sep. 18, 2002

By James Etheridge

With New Premises, Tropos Launches €15M Funding Round

Sep. 11, 2002

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 13, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 13, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.